Entrada Therapeutics Stock Quote TRDA - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

14.80

Bid

11.63

Ask

15.64

Volume

82,033

14.62 Day's Range 15.6299

10.7501 52 Week Range 18.17

Market Cap

550.553M

Previous Close

15.39

Open

15.32

Last Trade

14.8

Last Trade Time

Financial Volume

$ 1,226,801

VWAP

14.955

Average Volume (3m)

125,429

Shares Outstanding

37,199,550

Dividend Yield

PE Ratio

-82.36

Earnings Per Share (EPS)

-0.18

Revenue

129.01M

Net Profit

-6.69M

Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, an... Entrada Therapeutics Inc mission is to transform the treatment of devastating diseases and improve patients quality of life by developing intracellular biologics. Leveraging its proprietary Endosomal Escape Vehicle platform, Entrada is creating a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.entradatx.com

Headquarters

Wilmington, Delaware, USA

Founded

Entrada Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TRDA. The last closing price for Entrada Therapeutics was $15.39. Over the last year, Entrada Therapeutics shares have traded in a share price range of $ 10.7501 to $ 18.17.

Entrada Therapeutics currently has 37,199,550 shares outstanding. The market capitalization of Entrada Therapeutics is $572.50 million. Entrada Therapeutics has a price to earnings ratio (PE ratio) of -82.36.

Form 144 - Report of proposed sale of securities

Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program

- Second annual DREAMS Grant Program awards $25,000 each to three U.S.-based non-profit organizations working to achieve greater equality for those living with Duchenne - - Announced in...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.71	-15.4768703598	17.51	17.845	14.62	134926	16.21576589	CS
4	0.42	2.9207232267	14.38	17.845	13.71	144766	16.27884362	CS
12	-1.2	-7.5	16	18.17	13.64	125429	16.09207028	CS
26	2.29	18.3053557154	12.51	18.17	11.35	98148	15.156643	CS
52	0.59	4.15200562984	14.21	18.17	10.7501	85317	14.87503223	CS
156	-11.7	-44.1509433962	26.5	36.85	5.12	90026	15.25092603	CS
260	-11.7	-44.1509433962	26.5	36.85	5.12	90026	15.25092603	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WHLRWheeler Real Estate Investment Trust Inc	$ 10.52 (154.11%)	80.5M
BLMZBloomZ Inc	$ 1.76 (117.82%)	145.44M
SMXTSolarMax Technology Inc	$ 1.49 (39.25%)	2.39M
BENFBeneficient	$ 2.045 (36.33%)	115.27M
WLGSWang and Lee Group Inc	$ 0.75 (29.67%)	227.2k
NBSTWNewbury Street Acquisition Corporation	$ 0.0503 (-32.93%)	5.7k
AZIAutozi Internet Technology Global Ltd	$ 1.28 (-29.28%)	631.28k
RENTRent the Runway Inc	$ 10.90 (-27.72%)	611.34k
SHPHShuttle Pharmaceuticals Holdings Inc	$ 1.63 (-24.88%)	968.38k
IVPInspire Veterinary Partners Inc	$ 0.8799 (-24.79%)	7.56M
NVDANVIDIA Corporation	$ 102.83 (-4.09%)	414.11M
SQQQProShares UltraPro Short QQQ	$ 9.72 (8.00%)	235.8M
XPONExpion360 Inc	$ 0.0683 (-4.74%)	164.86M
WTOUTime Limited	$ 0.068 (5.10%)	151.89M
BLMZBloomZ Inc	$ 1.76 (117.82%)	145.44M